Furnishings, Fixtures & Appliances
Build Your Comparison
Side-by-side financial analysisStock Comparison
ALH vs EMR vs ROK vs AME vs HON
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Industrial - Machinery
Industrial - Machinery
Conglomerates
ALH vs EMR vs ROK vs AME vs HON — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Furnishings, Fixtures & Appliances | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Conglomerates |
| Market Cap | $4.60B | $84.38B | $53.23B | $54.38B | $145.11B |
| Revenue (TTM) | $1.72B | $18.32B | $8.80B | $7.60B | $36.76B |
| Net Income (TTM) | $135M | $2.44B | $1.09B | $1.53B | $4.10B |
| Gross Margin | 37.2% | 52.7% | 52.5% | 36.6% | 36.9% |
| Operating Margin | 18.4% | 19.8% | 19.1% | 26.2% | 14.9% |
| Forward P/E | 20.9x | 23.2x | 36.6x | 29.2x | 21.8x |
| Total Debt | $2.00B | $13.76B | $3.65B | $2.28B | $34.58B |
| Cash & Equiv. | $150M | $1.54B | $468M | $458M | $12.49B |
ALH vs EMR vs ROK vs AME vs HON — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Emerson Electric Co. (EMR) | 100 | 242.9 | +142.9% |
| Rockwell Automation… (ROK) | 100 | 222.4 | +122.4% |
| AMETEK, Inc. (AME) | 100 | 265.7 | +165.7% |
| Honeywell Internati… (HON) | 100 | 158.4 | +58.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALH vs EMR vs ROK vs AME vs HON
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALH has the current edge in this matchup, primarily because of its strength in growth and value.
- 13.3% revenue growth vs ROK's 1.0%
- Lower P/E (20.9x vs 36.6x)
EMR is the clearest fit if your priority is growth exposure.
- Rev growth 3.0%, EPS growth 17.8%, 3Y rev CAGR 9.3%
ROK is the #2 pick in this set and the best alternative if momentum and efficiency is your priority.
- +48.9% vs HON's +5.3%
- 9.7% ROA vs ALH's 4.6%, ROIC 15.1% vs 10.8%
AME is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 424.2% 10Y total return vs ROK's 338.0%
- PEG 2.61 vs HON's 11.87
- 20.1% margin vs ALH's 7.8%
HON ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 8 yrs, beta 0.84, yield 2.0%
- Lower volatility, beta 0.84, current ratio 1.32x
- Beta 0.84, yield 2.0%, current ratio 1.32x
- Beta 0.84 vs EMR's 1.58
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.3% revenue growth vs ROK's 1.0% | |
| Value | Lower P/E (20.9x vs 36.6x) | |
| Quality / Margins | 20.1% margin vs ALH's 7.8% | |
| Stability / Safety | Beta 0.84 vs EMR's 1.58 | |
| Dividends | 2.0% yield, 8-year raise streak, vs EMR's 1.4%, (1 stock pays no dividend) | |
| Momentum (1Y) | +48.9% vs HON's +5.3% | |
| Efficiency (ROA) | 9.7% ROA vs ALH's 4.6%, ROIC 15.1% vs 10.8% |
ALH vs EMR vs ROK vs AME vs HON — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ALH vs EMR vs ROK vs AME vs HON — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AME leads in 1 of 6 categories
ALH leads 1 • ROK leads 1 • EMR leads 0 • HON leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AME leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 21.4x ALH's $1.7B. AME is the more profitable business, keeping 20.1% of every revenue dollar as net income compared to ALH's 7.8%. On growth, ROK holds the edge at +11.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.7B | $18.3B | $8.8B | $7.6B | $36.8B |
| EBITDAEarnings before interest/tax | $409M | $4.7B | $1.9B | $2.3B | $6.5B |
| Net IncomeAfter-tax profit | $135M | $2.4B | $1.1B | $1.5B | $4.1B |
| Free Cash FlowCash after capex | $216M | $3.1B | $1.3B | $1.7B | $4.2B |
| Gross MarginGross profit ÷ Revenue | +37.2% | +52.7% | +52.5% | +36.6% | +36.9% |
| Operating MarginEBIT ÷ Revenue | +18.4% | +19.8% | +19.1% | +26.2% | +14.9% |
| Net MarginNet income ÷ Revenue | +7.8% | +13.3% | +12.4% | +20.1% | +11.2% |
| FCF MarginFCF ÷ Revenue | +12.6% | +17.0% | +15.2% | +22.4% | +11.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.6% | +2.9% | +11.8% | +11.3% | -6.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +100.0% | +28.2% | +39.6% | +14.5% | -41.9% |
Valuation Metrics
ALH leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 31.1x trailing earnings, HON trades at a 50% valuation discount to ROK's 61.8x P/E. Adjusting for growth (PEG ratio), AME offers better value at 3.32x vs HON's 16.95x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4.6B | $84.4B | $53.2B | $54.4B | $145.1B |
| Enterprise ValueMkt cap + debt − cash | $6.4B | $96.6B | $56.4B | $56.2B | $167.2B |
| Trailing P/EPrice ÷ TTM EPS | 51.71x | 37.29x | 61.77x | 37.10x | 31.12x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.86x | 23.16x | 36.64x | 29.16x | 21.79x |
| PEG RatioP/E ÷ EPS growth rate | — | 8.26x | — | 3.32x | 16.95x |
| EV / EBITDAEnterprise value multiple | 15.69x | 19.13x | 32.27x | 29.91x | 21.02x |
| Price / SalesMarket cap ÷ Revenue | 2.69x | 4.68x | 6.38x | 7.35x | 3.88x |
| Price / BookPrice ÷ Book value/share | 13.55x | 4.21x | 14.44x | 5.17x | 9.53x |
| Price / FCFMarket cap ÷ FCF | 29.14x | 31.64x | 39.20x | 32.54x | 26.91x |
Profitability & Efficiency
ROK leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ALH delivers a 105.7% return on equity — every $100 of shareholder capital generates $106 in annual profit, vs $12 for EMR. AME carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALH's 5.09x. On the Piotroski fundamental quality scale (0–9), ROK scores 8/9 vs HON's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +105.7% | +12.1% | +29.6% | +14.4% | +23.1% |
| ROA (TTM)Return on assets | +4.6% | +5.8% | +9.7% | +9.6% | +5.3% |
| ROICReturn on invested capital | +10.8% | +8.2% | +15.1% | +12.1% | +12.6% |
| ROCEReturn on capital employed | +13.3% | +10.0% | +18.5% | +15.0% | +12.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 8 | 7 | 6 |
| Debt / EquityFinancial leverage | 5.09x | 0.68x | 0.98x | 0.21x | 2.24x |
| Net DebtTotal debt minus cash | $1.8B | $12.2B | $3.2B | $1.8B | $22.1B |
| Cash & Equiv.Liquid assets | $150M | $1.5B | $468M | $458M | $12.5B |
| Total DebtShort + long-term debt | $2.0B | $13.8B | $3.6B | $2.3B | $34.6B |
| Interest CoverageEBIT ÷ Interest expense | 3.47x | 6.46x | 9.06x | 23.34x | 3.92x |
Total Returns (Dividends Reinvested)
Evenly matched — EMR and AME each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AME five years ago would be worth $18,579 today (with dividends reinvested), compared to $10,834 for ALH. Over the past 12 months, ROK leads with a +48.9% total return vs HON's +5.3%. The 3-year compound annual growth rate (CAGR) favors EMR at 21.9% vs ALH's 2.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +25.7% | +11.7% | +19.6% | +13.8% | +18.1% |
| 1-Year ReturnPast 12 months | +8.3% | +18.8% | +48.9% | +34.3% | +5.3% |
| 3-Year ReturnCumulative with dividends | +8.3% | +81.0% | +55.2% | +55.1% | +20.8% |
| 5-Year ReturnCumulative with dividends | +8.3% | +74.7% | +83.4% | +85.8% | +17.4% |
| 10-Year ReturnCumulative with dividends | +8.3% | +220.4% | +338.0% | +424.2% | +139.5% |
| CAGR (3Y)Annualised 3-year return | +2.7% | +21.9% | +15.8% | +15.8% | +6.5% |
Risk & Volatility
Evenly matched — ROK and HON each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.84 beta — it tends to amplify market swings less than EMR's 1.58 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ROK currently trades 99.6% from its 52-week high vs EMR's 91.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.26x | 1.58x | 1.50x | 0.91x | 0.84x |
| 52-Week HighHighest price in past year | $27.48 | $165.15 | $475.92 | $243.18 | $248.18 |
| 52-Week LowLowest price in past year | $18.64 | $122.64 | $305.44 | $174.43 | $186.76 |
| % of 52W HighCurrent price vs 52-week peak | +97.9% | +91.2% | +99.6% | +97.6% | +92.3% |
| RSI (14)Momentum oscillator 0–100 | 57.6 | 62.4 | 55.1 | 54.9 | 55.9 |
| Avg Volume (50D)Average daily shares traded | 674K | 2.5M | 624K | 1.0M | 4.2M |
Analyst Outlook
Evenly matched — EMR and HON each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ALH as "Buy", EMR as "Buy", ROK as "Hold", AME as "Buy", HON as "Buy". Consensus price targets imply 19.0% upside for ALH (target: $32) vs 0.3% for ROK (target: $475). For income investors, HON offers the higher dividend yield at 2.02% vs AME's 0.52%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $32.00 | $162.29 | $475.13 | $250.00 | $249.64 |
| # AnalystsCovering analysts | 3 | 41 | 39 | 29 | 28 |
| Dividend YieldAnnual dividend ÷ price | — | +1.4% | +1.1% | +0.5% | +2.0% |
| Dividend StreakConsecutive years of raises | 1 | 54 | 16 | 6 | 8 |
| Dividend / ShareAnnual DPS | — | $2.10 | $5.23 | $1.23 | $4.63 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | +1.5% | +0.8% | +0.8% | +2.6% |
AME leads in 1 of 6 categories (Income & Cash Flow). ALH leads in 1 (Valuation Metrics). 3 tied.
ALH vs EMR vs ROK vs AME vs HON: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ALH or EMR or ROK or AME or HON a better buy right now?
For growth investors, Alliance Laundry Holdings Inc.
(ALH) is the stronger pick with 13. 3% revenue growth year-over-year, versus 1. 0% for Rockwell Automation, Inc. (ROK). Honeywell International Inc. (HON) offers the better valuation at 31. 1x trailing P/E (21. 8x forward), making it the more compelling value choice. Analysts rate Alliance Laundry Holdings Inc. (ALH) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ALH or EMR or ROK or AME or HON?
On trailing P/E, Honeywell International Inc.
(HON) is the cheapest at 31. 1x versus Rockwell Automation, Inc. at 61. 8x. On forward P/E, Alliance Laundry Holdings Inc. is actually cheaper at 20. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: AMETEK, Inc. wins at 2. 61x versus Honeywell International Inc. 's 11. 87x.
03Which is the better long-term investment — ALH or EMR or ROK or AME or HON?
Over the past 5 years, AMETEK, Inc.
(AME) delivered a total return of +85. 8%, compared to +8. 3% for Alliance Laundry Holdings Inc. (ALH). Over 10 years, the gap is even starker: AME returned +424. 2% versus ALH's +8. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ALH or EMR or ROK or AME or HON?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 84β versus Emerson Electric Co. 's 1. 58β — meaning EMR is approximately 88% more volatile than HON relative to the S&P 500. On balance sheet safety, AMETEK, Inc. (AME) carries a lower debt/equity ratio of 21% versus 5% for Alliance Laundry Holdings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ALH or EMR or ROK or AME or HON?
By revenue growth (latest reported year), Alliance Laundry Holdings Inc.
(ALH) is pulling ahead at 13. 3% versus 1. 0% for Rockwell Automation, Inc. (ROK). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ALH or EMR or ROK or AME or HON?
AMETEK, Inc.
(AME) is the more profitable company, earning 20. 0% net margin versus 6. 0% for Alliance Laundry Holdings Inc. — meaning it keeps 20. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AME leads at 26. 2% versus 17. 1% for ROK. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ALH or EMR or ROK or AME or HON more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, AMETEK, Inc. (AME) is the more undervalued stock at a PEG of 2. 61x versus Honeywell International Inc. 's 11. 87x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Alliance Laundry Holdings Inc. (ALH) trades at 20. 9x forward P/E versus 36. 6x for Rockwell Automation, Inc. — 15. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALH: 19. 0% to $32. 00.
08Which pays a better dividend — ALH or EMR or ROK or AME or HON?
In this comparison, HON (2.
0% yield), EMR (1. 4% yield), ROK (1. 1% yield), AME (0. 5% yield) pay a dividend. ALH does not pay a meaningful dividend and should not be held primarily for income.
09Is ALH or EMR or ROK or AME or HON better for a retirement portfolio?
For long-horizon retirement investors, AMETEK, Inc.
(AME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 91), 0. 5% yield, +424. 2% 10Y return). Both have compounded well over 10 years (AME: +424. 2%, ALH: +8. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ALH and EMR and ROK and AME and HON?
These companies operate in different sectors (ALH (Consumer Cyclical) and EMR (Industrials) and ROK (Industrials) and AME (Industrials) and HON (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
EMR, ROK, AME, HON pay a dividend while ALH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.